Health Care

Why Is Dyne Therapeutics Stock Soaring On Monday?
Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
Medtronic's Heart Catheter Achieves Safety And Efficacy Goals In Patients With Irregular Heartbeat
Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
Medtronic's Heart Catheter Achieves Safety And Efficacy Goals In Patients With Irregular Heartbeat
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Wellness Platform Hims & Hers Health Adds GLP-1 Injections For Weight Loss, Stock Soars

Health Care Recent News

Esperion Therapeutics/Otsuka Partnered Cholesterol Drug Shows Effective In Japan Study
Esperion Therapeutics and Otsuka Pharmaceutical report Phase 3 trial results for bempedoic acid in Japan, achieving significant LDL-C reduction in hypercholesterolemia patients. With no serious adverse events, a New Drug Application is planned for late 2024.
Should You Invest in the Vanguard Health Care ETF?
Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Vanguard Health Care ETF (ARCA:VHT), a passively managed exchange traded fund launched on 01/26/2004.
European Commission Requests Reevaluation Of Opinion On PTC Therapeutics' Duchenne Dystrophy Drug; Pauses Annual Guidance
PTC Therapeutics announced that the European Commission has asked the CHMP to re-evaluate its negative opinion on the renewal of Translarna's conditional marketing authorization, keeping it available in Europe.
Elon Musk's Neuralink Receives FDA Approval For Second Human Brain Chip Implant: Report
Elon Musk's Neuralink Corp has reportedly received FDA approval to implant its brain chip in a second participant. This follows adjustments addressing issues from the first trial, where wires in the brain implant dislodged. The new approach involves placing the wires deeper into the brain, aiming to prevent similar problems. Noland Arbaugh, the first participant, experienced significant benefits but faced challenges due to these malfunctions.
Oracle's $28B Gamble On Cerner's AI-Driven Health Records System Backfires
Oracle Corporation made a $28 billion bet on Cerner Corporation to revolutionize healthcare. However, the electronic health records system has been linked to patient deaths, leading to a massive liability for Oracle.
Physical Injuries Are Easy To See And Cure, But Some Problems Don't Exist In Plain Sight, Slowly Eating Away Your Soul: 5 Essential Tools For Navigating Tough Days
Coping mechanisms for emotional well-being, including breathing exercises, music, a trusted confidant, faith, and self-care.
Days After Facing Lawsuit For Drug Use, Musk Says He Would Take Cocaine If It Boosted 'Long-Term Productivity'
Elon Musk recently expressed his views on drug use and its potential benefits on X, sparking a flurry of reactions.
I Once Worked At A Toxic Workplace. It Was So Suffocating That It Made Me Hate My Dream Job: Here Are 5 Warning Signs To Watch Out For So You Don't End Up Repeating The Mistakes I Made
Five warning signs of a toxic work environment, including lack of transparency, micromanagement, persistent negativity, high turnover rates, and blurred work-life boundaries.
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021.
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humira biosimilar erosion, drive growth with Skyrizi, Rinvoq, and emraclidine, and achieve a high single-digit CAGR from 2024 to 2029.
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and nursing shortages impact both companies' performance and share value.
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Moderna wins a crucial legal battle at the European Patent Office against Pfizer and BioNTech over Covid-19 vaccine patents.
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers